Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript

Cumberland Pharmaceuticals Inc. ( CPIX) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is ...
The Spectator Australia

Kemi Badenoch has said the unsayable on multiculturalism

The higher the failings of multiculturalism pile up, the greater the effort required to ignore the fetid mound of ...
Pharmabiz

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary ...

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...